A multi-targeted, barrier-penetrating inhalable nanoplatform for simultaneous immunomodulation and antifibrotic therapy in idiopathic pulmonary fibrosis

Materials Today Bio · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles